Chongde Hongxin is specializing in equity investment management.
Chongde Hongxin is specializing in equity investment management.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 11, 2018
ImmuneOnco Biopharma
|
Series A | $15.80M | Biopharma | — |
Jan 31, 2018
Senyint
|
Series D | — | Information Services | — |
Dec 16, 2016
Biosis Healing
|
Series B | ¥80M | Biotechnology | — |
Dec 31, 2012
Best
|
Series D | $10M | Information Technology | — |